| Drug Name: | human insulin (11061-68-0) |
|---|---|
| PubChem ID: | 118984375 |
| SMILES: | CC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC( |
| InchiKey: | PBGKTOXHQIOBKM-FHFVDXKLSA-N |
| Therapeutic Category: |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Hypoglycemia | Vasopressin V1a receptor (P37288) | Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men [ ADR Type 1 ] | Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men |
| Meiotic Maturation | Ribosomal protein S6 kinase (Q15418) | Insulin elicited an early (20-30 min) 3-fold stimulation of S6 peptide phosphorylating activity@a common S6 peptide kinase is activated as a consequence of short and long term insulin exposure@which greatly facilitate insulin-induced meiotic maturation [ ADR Type 1 ] | Insulin and progesterone activate a common synthetic ribosomal protein S6 peptide kinase in Xenopus oocytes |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category